Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats.
Intracerebral microdialysis
Neurochemistry
Obesity
Reward
Serotonin2C receptor
Single cell extracellular recordings
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
17
06
2019
revised:
01
12
2019
accepted:
15
12
2019
pubmed:
22
12
2019
medline:
7
4
2021
entrez:
22
12
2019
Statut:
ppublish
Résumé
Lorcaserin, which is a selective agonist of serotonin2C receptors (5-HT
Identifiants
pubmed: 31862271
pii: S0028-3908(19)30486-1
doi: 10.1016/j.neuropharm.2019.107915
pii:
doi:
Substances chimiques
Benzazepines
0
Receptor, Serotonin, 5-HT2C
0
Serotonin 5-HT2 Receptor Agonists
0
lorcaserin
637E494O0Z
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
107915Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.